Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer

Current Opinion in Oncology

Volumn 19, Issue 2, 2007, Pages 92-97

  De Pauw, Rebecca ^a   Van Meerbeeck, Jan P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Neoadjuvant chemotherapy; Nonsmall cell lung cancer; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; PACLITAXEL; PLATINUM; VINDESINE;

ADJUVANT CHEMOTHERAPY; BRONCHOPLEURAL FISTULA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EMPYEMA; ESOPHAGITIS; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PATIENT COMPLIANCE; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY FAILURE; REVIEW; THORACOTOMY; TREATMENT OUTCOME; UNITED STATES; VOMITING;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33846815283     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e328011bed9     Document Type: Review

References (23)

1. Mountain CF. The international system for staging lung cancer. Chest 1997; 111:1710-1717.
2. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall-cell lung cancer. N Eng J Med 2004; 350:351-360.
3. Hotta K, Matsuo K, Ueoka H, et al. Role of adjuvant chemotherapy in patients with resected nonsmall-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004; 22:3860-3867.
4. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin versus observation in resected nonsmall-cell lung cancer. N Eng J Med 2005; 352:2589-2597. Seminal paper reporting the results of adjuvant chemotherapy in NSCLC.
5. Douillard J, Rosell R, Delena M, et al. ANITA: phase III adjuvant vinorelbine and cisplatin versus observation in completely resected (stage I-III) nonsmall-cell lung cancer patients: final results after 70-month median follow-up . J Clin Oncol 2005; 23 (Suppl):16s; abstract 7013.
6. Frei E III. Clinical cancer research: an embattled species. Cancer 1982; 50:1979-1992.
7. Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable nonsmall-cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 2005; 49:13-23. Meta-analysis of adjuvant and neoadjuvant chemotherapy based on pooled literature data and showing a survival benefit for the combination of treatments.
8. Lordcick F, Stein HJ, Peschel C, et al. Neoadjuvant therapy in oesophagogastric cancer. Br J Surg 2004; 91:540-551.
9. Brücher BL, Stein HJ, Zimmerman F, et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 2004; 30:963-971.
10. Roth JA, Atkinson EN, Fossella T, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA nonsmall-cell lung cancer. Lung Cancer 1998; 21:1-6.
11. Rosell R, Gumez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA nonsmall-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999; 26:7-14.
12. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIA nonsmall cell lung cancer. J Clin Oncol 2002; 20:247-253.
13. Pisters KM, Ginsberg RJ, Giroux DJ, et al., Bimodality Lung Oncology Team. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 2000; 119:429-439.
14. Pisters K, Vallieres E, Bunn P. S9900: a phase III trial of surgery alone or surgery plus preoperative paclitaxel/carboplatine chemotherapy in early stage nonsmall cell lung cancer: preliminary results. J Clin Oncol 2005; 23 (Suppl):16s; abstract 7012.
15. Smith I, Groen HJM, van Meerbeeck J, et al. The impact of giving neo-adjuvant chemotherapy for patients with nonsmall cell lung cancer (NSCLC): data from the MRC LU22/NVALT/EORTC 08012 randomised clinical trial. Eur J Cancer 2005; 13:32; abstract 1121.
16. Scagliotti GV. Preliminary results of ChEST: A phase III study of surgery alone or surgery plus pre-operative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC). J Clin Oncol 2005; 23:626s.
17. Burdett S, Stewart L, Rydzewska, et al. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in nonsmall cell lung cancer. J Thoracic Oncology 2006; 1:611-621. Meta-analysis based on pooled literature data showing an improved outcome for the combination of neoadjuvant chemotherapy and surgery.
18. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 nonsmall cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2001; 18:2981-2989.
19. Albain KS, Scott C, Rusch V, et al. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) nonsmall cell lung cancer: Initial results from Intergroup Trial 0139 [abstract]. Proc Am Soc Clin Oncol 2003; 22:621.
20. Albain KS, Swann RS, Rusch V, et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) nonsmall cell lung cancer: Outcomes update on North American Intergroup 0139 [abstract]. J Clin Oncol 2005; 23 (16S):624s.
21. Van Meerbeeck J, Kramer G, van Schil P, et al. A randomized trial of radical surgery versus thoracic radiotherapy in patients with stage IIIA-N2 nonsmall cell lung cancer after response to induction chemotherapy (EORTC 08941). J Clin Oncol 2005; 23 (16S):624s.
22. Van Schil P, Van Meerbeeck J, Kramer G, et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Resp J 2005; 26:192-197. This manuscript describes the surgical results, including morbidity and mortality of the EORTC trial in stage IIIA-N2 NSCLC.
23. Thomas M, Macha HN, Ukena D, et al. Cisplatin/etoposide (PE) followed by twice-daily chemoradiation versus PE alone before surgery in stage III nonsmall cell lung cancer. A randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG) [abstract]. J Clin Oncol 2004; 22:14S.